ATP and A1 adenosine receptor agonists mobilize intracellular calcium and activate K+ and Cl- currents in normal and cystic fibrosis airway epithelial cells

J Biol Chem. 1993 Nov 25;268(33):24779-84.

Abstract

The effect of purinergic compounds on [Ca2+]i and membrane currents of cell lines derived from the airway epithelium of normal and cystic fibrosis individuals has been investigated. 2-Chloroadenosine (2-CADO), as well as other agonists of the A1 adenosine receptors, causes a transient elevation of cytosolic [Ca2+] that is antagonized by the A1 adenosine receptor antagonist 8-cyclopentyl-1,3 dipropylxanthine (DPCPX). ATP is also effective, but at a lower extent. The [Ca2+]i increase induced by 2-CADO and ATP is abolished by preincubation with phorbol 12-myristate 13-acetate and the Ca(2+)-ATPase inhibitor thapsigargin. This latter result suggests that purinergic agonists mobilize Ca2+ from inositol 1,4,5-trisphosphate-sensitive stores. Pertussis toxin completely inhibits the effect of 2-CADO, whereas only it partially affects that of ATP, suggesting the involvement of different types of G proteins. Perforated patch clamp experiments carried out in both current clamp and voltage clamp modes show that 2-CADO and ATP activate K(+)- and Cl(-)-selective membrane currents, with a mechanism inhibited by preincubation with DPCPX and thapsigargin. These data indicate that activation of adenosine A1 receptor, in a similar way to ATP receptor, causes [Ca2+]i increase and ion channels activation through a transduction mechanism that is not impaired in cystic fibrosis airway epithelial cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 2-Chloroadenosine / pharmacology
  • Adenosine Triphosphate / pharmacology*
  • Adult
  • Calcium / metabolism*
  • Cells, Cultured
  • Chloride Channels / drug effects
  • Chloride Channels / metabolism
  • Cystic Fibrosis / metabolism*
  • Cystic Fibrosis / pathology
  • Humans
  • Membrane Potentials
  • Potassium Channels / drug effects
  • Potassium Channels / metabolism
  • Purinergic P1 Receptor Antagonists
  • Receptors, Purinergic P1 / drug effects*
  • Terpenes / pharmacology
  • Thapsigargin
  • Trachea / metabolism*
  • Trachea / physiology
  • Trachea / physiopathology
  • Xanthines / pharmacology

Substances

  • Chloride Channels
  • Potassium Channels
  • Purinergic P1 Receptor Antagonists
  • Receptors, Purinergic P1
  • Terpenes
  • Xanthines
  • 2-Chloroadenosine
  • Thapsigargin
  • Adenosine Triphosphate
  • 1,3-dipropyl-8-cyclopentylxanthine
  • Calcium